CDKN1A/p21 Polyclonal Antibody, PerCP-Cy5.5 Conjugated, PerCP/Cy5.5, Rabbit

Artikelnummer: BSS-BS-22795R-PERCP-CY5.5
Artikelname: CDKN1A/p21 Polyclonal Antibody, PerCP-Cy5.5 Conjugated, PerCP/Cy5.5, Rabbit
Artikelnummer: BSS-BS-22795R-PERCP-CY5.5
Hersteller Artikelnummer: bs-22795R-PerCP-Cy5.5
Alternativnummer: BSS-BS-22795R-PERCP-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: PerCP/Cy5.5
Alternative Synonym: p21, P21 protein, Activating Fragment 1, CAP20, Cation chloride cotransporter-interacting protein 1, CDK Interacting Protein 1, CDK-interacting protein 1, CDKI, CDKN 1, CDKN1, CDKN1A, CIP1, Cyclin Dependent Kinase Inhibitor 1A, Cyclin-dependent kinase inhibitor 1, Cyclin-dependent kinase inhibitor 1A (P21), Cyclin-dependent kinase inhibitor 1A (p21, Cip1), DNA Synthesis Inhibitor, MDA 6, MDA-6, MDA6, Melanoma Differentiation Associated Protein 6, Melanoma differentiation-associated protein 6, Melanoma differentiation-associated protein, p21CIP1, p21WAF, PIC1, SDI1, SLC12A9, WAF1, Wildtype p53 Activating Fragment 1, Wildtype p53-activated fragment 1, CDN1A_HUMAN.
May be the important intermediate by which p53/TP53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 12575
UniProt: P39689
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from mouse CDKN1A/p21
Target-Kategorie: CDKN1A/p21
Application Verdünnung: IF(IF=1:100-500)